Live
Endpoints News#ASCO26: Personalized cancer vaccines may help brain cancer patients live longerEndpoints News#ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts sayFierceBiotechIn next-gen IO race in NSCLC, BioNTech/BMS and Pfizer are divided on overall survival approachIlluminaIllumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance SingaporeCellDecoding the spatiotemporal development of human meningesCellFronto-insular circuit mechanisms of accelerated intermittent theta burst stimulationCellPhysiological brain clearance architecture revealed by neuronal protein tracingFierceBiotechASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’Endpoints NewsCan AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and moreAgilentMettler-Toledo International vs Agilent Technologies: Which Is the Stronger Buy Today? - TrefisIlluminaIllumina Ducks DNA Sequence Rival's Antitrust Suit, For Now - Law360BioPharma DiveAt ASCO, Merck makes case for a ‘cornerstone’ cancer drug
Endpoints News Apr 15, 2026

Scribing startup Abridge adds NEJM, JAMA as it moves into medical AI search

Scribing startup Abridge adds NEJM, JAMA as it moves into medical AI search

Body unavailable. Use the original source.